Differential responses of disease‐related GRIN variants located in pore‐forming M2 domain of N‐methyl‐D ‐aspartate receptor to FDA ‐approved inhibitors
Journal of Neurochemistry · 2024
DOI: 10.1111/jnc.15942 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neurochemistry, 2024. Verfasst von Rui Song und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Receptors, N-Methyl-D-Aspartate. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NINDS NIH HHS, Eunice Kennedy Shriver National Institute of Child Health and Human Development.
Abstract (Originalsprache)
N‐methyl‐D‐aspartate receptors (NMDAR), ionotropic glutamate receptors, mediate a slow component of excitatory synaptic transmission in the central nervous system and play a key role in normal brain function and development. Genetic variations in GRIN genes encoding NMDAR subunits that alter the receptor's functional characteristics are associated with a wide range of neurological and neuropsychiatric conditions. Pathological GRIN variants located in the M2 re‐entrant loop lining the channel pore cause significant functional changes, the most consequential alteration being a reduction in voltage‐dependent Mg 2+ inhibition. Voltage‐dependent Mg 2+ block is a unique feature of NMDAR biology whereby channel activation requires both ligand binding and postsynaptic membrane depolarization. Thus, loss of NMDAR Mg 2+ block will have a profound impact on synaptic function and plasticity. Here, we choose 11 missense variants within the GRIN1 , GRIN2A , and GRIN2B genes that alter residues located in the M2 loop and significantly reduce Mg 2+ inhibition. Each variant was evaluated for tolerance to genetic variation using the 3‐dimensional structure and assessed for functional rescue pharmacology via electrophysiological recordings. Three FDA‐approved NMDAR drugs—memantine, dextromethorphan, and ketamine—were chosen based on their ability to bind near the M2 re‐entrant loop, potentially rectifying dysregulated NMDAR function by supplementing the reduced voltage‐dependent Mg 2+ block. These results provide insight of structural determinants of FDA‐approved NMDAR drugs at their binding sites in the channel pore and may further define conditions necessary for the use of such agents as potential rescue pharmacology. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, Georgia, USA.
- Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, Georgia, USA.
- Center for Functional Evaluation of Rare Variants (CFERV), Emory University School of Medicine, Atlanta, Georgia, USA.
- Emory Neurodegenerative Disease Center, Emory University School of Medicine, Atlanta, Georgia, USA.
ORCID-Profile: Riley E Perszyk, Chad R Camp, Jiahui Chen, Yinlong Li, Steven H Liang, Stephen F Traynelis, Hongjie Yuan
Förderung
- NIA NIH HHS
- NINDS NIH HHS
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- NICHD NIH HHS
- Uplifting Athletes Young Investigator Draft
- National Institute of Neurological Disorders and Stroke
- National Institute on Aging
Zitieren
APA
Song, R., Zhang, J., Perszyk, R. E., Camp, C. R., Tang, W., Kannan, V., Li, J., Xu, Y., Chen, J., Li, Y., Liang, S. H., Traynelis, S. F., & Yuan, H. (2024). Differential responses of disease‐related GRIN variants located in pore‐forming M2 domain of N‐methyl‐D ‐aspartate receptor to FDA ‐approved inhibitors. Journal of Neurochemistry. https://doi.org/10.1111/jnc.15942
Vancouver
Song R, Zhang J, Perszyk RE, Camp CR, Tang W, Kannan V, et al. Differential responses of disease‐related GRIN variants located in pore‐forming M2 domain of N‐methyl‐D ‐aspartate receptor to FDA ‐approved inhibitors. Journal of Neurochemistry. 2024. doi:10.1111/jnc.15942
BibTeX
@article{Song2024,
author = {Song, Rui and Zhang, Jin and Perszyk, Riley E and Camp, Chad R and Tang, Weiting and Kannan, Varun and Li, Jia and Xu, Yuchen and Chen, Jiahui and Li, Yinlong and Liang, Steven H and Traynelis, Stephen F and Yuan, Hongjie},
title = {Differential responses of disease‐related GRIN variants located in pore‐forming M2 domain of N‐methyl‐D ‐aspartate receptor to FDA ‐approved inhibitors},
journal = {Journal of Neurochemistry},
year = {2024},
doi = {10.1111/jnc.15942}
}
EUVIMED